Deficient CD4+ CD25+ FOXP3+ T Regulatory Cells in Acquired Aplastic Anemia

Overview

Journal Blood

Publisher Elsevier

Specialty Hematology

Date 2007 Apr 28

PMID 17463169

Citations 91

Authors

Elena E Solomou

Katayoun Rezvani

Stephan Mielke

Daniela Malide

Keyvan Keyvanfar

Valeria Visconte

Sachiko Kajigaya

A John Barrett

Neal S Young

Affiliations

Soon will be listed here.

Abstract

Regulatory T cells are believed to control the development and progression of autoimmunity by suppressing autoreactive T cells. Decreased numbers of CD4(+)CD25(+) FOXP3(+) T cells (Tregs) are associated with impaired immune homeostasis and development of autoimmune diseases. The transcription factors FOXP3 and NFAT1 have key roles in regulatory T-cell development and function. We show that Tregs are decreased at presentation in almost all patients with aplastic anemia; FOXP3 protein and mRNA levels also are significantly lower in patients with aplastic anemia and NFAT1 protein levels are decreased or absent. Transfection of FOXP3-deficient CD4(+)CD25(+) T cells from patients with a plasmid encoding wild-type NFAT1 resulted in increased FOXP3 expression in these cells. By NFAT1 knockdown in CD4(+)CD25(+) T cells, FOXP3 expression was decreased when NFAT1 expression was decreased. Our findings indicate that decreased NFAT1 could explain low FOXP3 expression and diminished Treg frequency in aplastic anemia. Treg defects are now implicated in autoimmune marrow failure.

Citing Articles

Dysregulated T-cell homeostasis and decreased CD30 Treg proliferating in aplastic anemia.

Sun N, Zhang M, Kong J, Li J, Dong Y, Wang X Heliyon. 2024; 10(15):e35775.

PMID: 39170389 PMC: 11337026. DOI: 10.1016/j.heliyon.2024.e35775.

Umbilical Cord Blood-Derived Cells Can Reconstruct Hematopoiesis in an Aplastic Anemia Animal Model.

Chen Z, Yang C, Ji J, Chen M, Han B Stem Cells Int. 2024; 2024:4095268.

PMID: 39161367 PMC: 11333133. DOI: 10.1155/2024/4095268.

The Dual Role of the NFATc2/galectin-9 Axis in Modulating Tumor-Initiating Cell Phenotypes and Immune Suppression in Lung Adenocarcinoma.

Xiao Z, Wang S, Chen J, Li Y, Jiang Y, Tin V Adv Sci (Weinh). 2024; 11(20):e2306059.

PMID: 38528665 PMC: 11132051. DOI: 10.1002/advs.202306059.

Formononetin reverses Treg/Th17 imbalance in immune-mediated bone marrow failure mice by regulating the PI3K/Akt signaling pathway.

Lan H, Qiu W, Wu J, Hu Z, Zhang X, Zhu L Chin Med. 2024; 19(1):55.

PMID: 38528555 PMC: 10962105. DOI: 10.1186/s13020-024-00919-9.

The role of TIM3 NK and TIM3 NK cells in the immune pathogenesis of severe aplastic anemia.

Ding S, Zhang T, Lei Y, Liu C, Liu Z, Fu R J Transl Int Med. 2024; 12(1):96-105.

PMID: 38525441 PMC: 10956726. DOI: 10.2478/jtim-2023-0104.

References

Shevach E, Dipaolo R, Andersson J, Zhao D, Stephens G, Thornton A . The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells. Immunol Rev. 2006; 212:60-73. DOI: 10.1111/j.0105-2896.2006.00415.x. View

Viglietta V, Baecher-Allan C, Weiner H, Hafler D . Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med. 2004; 199(7):971-9. PMC: 2211881. DOI: 10.1084/jem.20031579. View

Sakaguchi S . Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol. 2005; 6(4):345-52. DOI: 10.1038/ni1178. View

Miyara M, Amoura Z, Parizot C, Badoual C, Dorgham K, Trad S . Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol. 2005; 175(12):8392-400. DOI: 10.4049/jimmunol.175.12.8392. View

Beissert S, Schwarz A, Schwarz T . Regulatory T cells. J Invest Dermatol. 2006; 126(1):15-24. DOI: 10.1038/sj.jid.5700004. View

Sutmuller R, Den Brok M, Kramer M, Bennink E, Toonen L, Kullberg B . Toll-like receptor 2 controls expansion and function of regulatory T cells. J Clin Invest. 2006; 116(2):485-94. PMC: 1332026. DOI: 10.1172/JCI25439. View

Mantel P, Ouaked N, Ruckert B, Karagiannidis C, Welz R, Blaser K . Molecular mechanisms underlying FOXP3 induction in human T cells. J Immunol. 2006; 176(6):3593-602. DOI: 10.4049/jimmunol.176.6.3593. View

Longhi M, Hussain M, Mitry R, Arora S, Mieli-Vergani G, Vergani D . Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis. J Immunol. 2006; 176(7):4484-91. DOI: 10.4049/jimmunol.176.7.4484. View

Solomou E, Keyvanfar K, Young N . T-bet, a Th1 transcription factor, is up-regulated in T cells from patients with aplastic anemia. Blood. 2006; 107(10):3983-91. PMC: 1895294. DOI: 10.1182/blood-2005-10-4201. View

10.

Beyer M, Schultze J . Regulatory T cells in cancer. Blood. 2006; 108(3):804-11. DOI: 10.1182/blood-2006-02-002774. View

11.

Rudensky A, Gavin M, Zheng Y . FOXP3 and NFAT: partners in tolerance. Cell. 2006; 126(2):253-6. DOI: 10.1016/j.cell.2006.07.005. View

12.

Wu Y, Borde M, Heissmeyer V, Feuerer M, Lapan A, Stroud J . FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell. 2006; 126(2):375-87. DOI: 10.1016/j.cell.2006.05.042. View

13.

Young N, Calado R, Scheinberg P . Current concepts in the pathophysiology and treatment of aplastic anemia. Blood. 2006; 108(8):2509-19. PMC: 1895575. DOI: 10.1182/blood-2006-03-010777. View

14.

Wan Y, Flavell R . Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature. 2007; 445(7129):766-70. DOI: 10.1038/nature05479. View

15.

Solomou E, Gibellini F, Stewart B, Malide D, Berg M, Visconte V . Perforin gene mutations in patients with acquired aplastic anemia. Blood. 2007; 109(12):5234-7. PMC: 1890825. DOI: 10.1182/blood-2006-12-063495. View

16.

Rezvani K, Mielke S, Ahmadzadeh M, Kilical Y, Savani B, Zeilah J . High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT. Blood. 2006; 108(4):1291-7. PMC: 1895877. DOI: 10.1182/blood-2006-02-003996. View

17.

Solomou E, Juang Y, Tsokos G . Protein kinase C-theta participates in the activation of cyclic AMP-responsive element-binding protein and its subsequent binding to the -180 site of the IL-2 promoter in normal human T lymphocytes. J Immunol. 2001; 166(9):5665-74. DOI: 10.4049/jimmunol.166.9.5665. View

18.

Kukreja A, Cost G, Marker J, Zhang C, Sun Z, Lin-Su K . Multiple immuno-regulatory defects in type-1 diabetes. J Clin Invest. 2002; 109(1):131-40. PMC: 150819. DOI: 10.1172/JCI13605. View

19.

Herndon T, Juang Y, Solomou E, Rothwell S, Gourley M, Tsokos G . Direct transfer of p65 into T lymphocytes from systemic lupus erythematosus patients leads to increased levels of interleukin-2 promoter activity. Clin Immunol. 2002; 103(2):145-53. DOI: 10.1006/clim.2002.5192. View

20.

Monticelli S, Rao A . NFAT1 and NFAT2 are positive regulators of IL-4 gene transcription. Eur J Immunol. 2002; 32(10):2971-8. DOI: 10.1002/1521-4141(2002010)32:10<2971::AID-IMMU2971>3.0.CO;2-G. View